Cargando…
Geroscience‐guided repurposing of FDA‐approved drugs to target aging: A proposed process and prioritization
Common chronic diseases represent the greatest driver of rising healthcare costs, as well as declining function, independence, and quality of life. Geroscience‐guided approaches seek to delay the onset and progression of multiple chronic conditions by targeting fundamental biological pathways of agi...
Autores principales: | Kulkarni, Ameya S., Aleksic, Sandra, Berger, David M., Sierra, Felipe, Kuchel, George A., Barzilai, Nir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009114/ https://www.ncbi.nlm.nih.gov/pubmed/35343051 http://dx.doi.org/10.1111/acel.13596 |
Ejemplares similares
-
BIOMARKER STRATEGIES FOR GEROSCIENCE-GUIDED CLINICAL TRIALS
por: Justice, Jamie N, et al.
Publicado: (2019) -
A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin
por: Justice, Jamie N., et al.
Publicado: (2020) -
Geroscience in the Age of COVID-19
por: Barzilai, Nir, et al.
Publicado: (2020) -
UPDATE IN GEROSCIENCE FOR NONBIOLOGISTS
por: Kuchel, George, et al.
Publicado: (2022) -
Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential
por: Lo, Yu-Chen, et al.
Publicado: (2017)